Profil
David Banks joined CV Therapeutics, Inc. in 2007 as Senior Vice President of Operations.
Previously, he was Vice President of Consumer Alliance Management of Johnson & Johnson and Vice President of Manufacturing.
Mr. Banks was Vice President of Manufacturing of ALZA Corporation from 1995 to 2001 and worked for Syntex.
He received an MBA from East Tennessee State University and a BS in Industrial Engineering from Tennessee Tech University.
Ehemalige bekannte Positionen von David Banks
| Unternehmen | Position | Ende |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Geschäftsführer | 02.05.2011 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.2001 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Ausbildung von David Banks
| East Tennessee State University | Masters Business Admin |
| Tennessee Technological University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
